ACM
CLVS

Antonetti Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Antonetti Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,500
Closed -$9K – 360
2022
Q3 		$9K Hold
7,500
– – 0.01% 227
2022
Q2 		$14K Hold
7,500
– – 0.01% 207
2022
Q1 		$15K Hold
7,500
– – 0.01% 226
2021
Q4 		$20K Sell
7,500
-3,200
-30% -$11.8K 0.02% 249
2021
Q3 		$48K Buy
+10,700
New +$51.5K 0.04% 158

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Antonetti Capital Management's CLVS Position: Q4 2022 in Review

Antonetti Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 7,500 shares — an estimated $9K sold.

Antonetti Capital Management first reported a position in CLVS in Q3 2021 and held it in 5 quarters. The position peaked at $48K in Q3 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Antonetti Capital Management reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Antonetti Capital Management sold 7,500 Clovis Oncology, Inc. shares in Q4 2022, an estimated $9K.
  • Antonetti Capital Management first reported a position in Clovis Oncology, Inc. in Q3 2021 and held it in 5 quarters.
  • Antonetti Capital Management's Clovis Oncology, Inc. position peaked at $48K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Antonetti Capital Management's 13F filing for Q4 2022, filed 1 Feb 2023.